PFO
TECH icon

Pathstone Family Office’s Bio-Techne TECH Stock Holding History

Pathstone Family Office’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$744K Buy
10,936
+3,788
+53% +$299K 0.01% 838
2023
Q2 		$584K Buy
+7,148
New +$575K 0.01% 690
2023
Q1 		– Sell
-18,318
Closed -$1.35M – 1484
2022
Q4 		$1.35M Buy
18,318
+3,026
+20% +$240K 0.01% 649
2022
Q3 		$1.09M Buy
+15,292
New +$1.32M 0.01% 688

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pathstone Family Office's TECH Position: Q3 2023 in Review

Pathstone Family Office increased its Bio-Techne (TECH) stake by 53% in Q3 2023, buying an estimated $299K and bringing the position to 10,936 shares worth $744K. The position accounts for 0.01% of the portfolio, ranked #838.

Pathstone Family Office first reported a position in TECH in Q3 2022 and has held it in 4 quarters since. The position peaked at $1.35M in Q4 2022. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

  • Pathstone Family Office held 10,936 shares of Bio-Techne worth $744K as of Q3 2023.
  • Pathstone Family Office bought 3,788 Bio-Techne shares in Q3 2023, an estimated $299K.
  • Bio-Techne made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #838 holding.
  • Pathstone Family Office first reported a position in Bio-Techne in Q3 2022 and has held it in 4 quarters since.
  • Pathstone Family Office's Bio-Techne position peaked at $1.35M in Q4 2022.
  • 530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.